glp 1 drugs moa Glucagon-like peptide-1 GLP-1 Receptor Agonists as Treatments
Description
Exenatide and lixisenatide are exendin 4-based agents, while albiglutide, dulaglutide, liraglutide, and semaglutide are GLP-1-based agents
This is because, for some people, sudden reductions in blood sugar levels can make symptoms of retinopathy worse
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury
Viridian Weight Support Programme provides recipes which contain whole foods, making them nutritious and help to promote satiety
Other potential risks include gallbladder problems (including gallstones), kidney problems (particularly in patients with existing kidney disease who become dehydrated), and hypoglycemia when combined with other diabetes medications
Diabetes Obes Metab (2017) 19(9):124251
